Misconstruing Whistleblower Immunity Under the Defend Trade Secrets Act

Law and Innovation: Evidence from the Uniform Trade Secrets Act

Most research and policy on protecting innovation focus on patents. Yet, almost all technology managers report secrecy to be more important than patents. Here, I show theoretically that stronger secrecy laws could increase or reduce R&D. By reducing spillovers, secrecy laws might reduce or raise the return to R&D, depending on whether spillover and own R&D are complements or substitutes. By str...

Secrets of the Trade

President Obama has discovered first-hand how difficult wrangling the interests of a dozen nations can be. For six years, the Trans-Pacific Partnership (TPP) has been in negotiations and might prove to be Obama’s crowning foreign policy achievement. If the 12-nation Free Trade Agreement (FTA) passes, it will shape the future of economic development in the Asia-Pacific and cement the U.S. as the...

The constitutional protection of trade secrets and patents under the Biologics Price Competition and Innovation Act of 2009.

The Biologics Price Competition and Innovation Act of 2009 ("Biosimilars Act") is for the field of pharmaceutical products the single most important legislative development since passage of the Drug Price Competition and Patent Term Restoration Act of 1984 ("Hatch-Waxman Act"), on which portions of the Biosimilars Act are clearly patterned. Congress revised section 351 of the Public Health Serv...

The Criminalization of the Theft of Trade Secrets: An Analysis of the Economic Espionage Act

'I had to act': in conversation with a whistleblower.